Better Option Than MEDVi in 2026? What to Look For and Where to Find It
MEDVi is a functional GLP-1 telehealth platform. It connects patients with providers, fills prescriptions, and delivers medication. For many patients, that is enough. But "functional" and "best" are not the same thing, and a growing number of MEDVi users are asking whether they could do better.
Better is subjective, of course. It depends on what matters most to you. Better clinical care? Better pricing? Better medication options? Better communication with your provider? We evaluated the top GLP-1 programs in 2026 across the dimensions that matter most to patients and laid out where each one excels.
Why People Ask If There Is Something Better Than MEDVi
Patients who are actively searching for a better option usually have a specific frustration driving the search:
- Clinical interactions feel shallow. Brief provider consultations that follow a script rather than responding to your individual situation leave patients feeling like a number rather than a patient.
- Dosing is not personalized. Standard titration schedules work for some patients but not all. When side effects are significant or weight loss stalls, patients want a provider who will deviate from the standard protocol based on their response.
- Limited treatment options. GLP-1 therapy is increasingly used alongside peptides and other compounds. Patients who want a comprehensive protocol find MEDVi's formulary limiting.
- Results have plateaued. When progress stalls, patients naturally wonder if a different approach or a more engaged provider could restart their momentum.
- The experience does not match the price. Paying premium prices for a basic experience creates a disconnect that pushes patients to look elsewhere.
Top Options That May Be Better Than MEDVi
1. Form Blends: Best for Physician-Supervised, Personalized Care
Form Blends was built around a premise that most GLP-1 telehealth platforms underdeliver on: genuine physician involvement. Patients work directly with a licensed physician who designs their protocol, monitors their response, and makes adjustments based on how they are actually doing, not based on a standardized schedule.
The formulary is another differentiator. Form Blends offers compounded semaglutide ($199/month), tirzepatide ($249/month), and peptide therapies including BPC-157. For patients whose needs extend beyond basic GLP-1 prescribing, this breadth matters significantly.
The program runs on flat-rate, transparent pricing with no contracts. If you are coming from MEDVi and your primary complaint is that you do not feel like you have a real doctor managing your care, Form Blends addresses that directly.
Better than MEDVi for: Clinical engagement, personalized protocols, peptide therapy access
Comparable to MEDVi for: Pricing, enrollment process
2. Ro Body: Best for Data-Driven Medical Oversight
Ro takes a more clinical approach than most telehealth GLP-1 providers. Lab monitoring is part of the standard program, and dosing decisions are informed by objective data rather than patient self-reports alone. Their in-house pharmacy adds a layer of quality control that matters when you are using compounded medications.
The care model is more structured and evidence-based than what you typically get with MEDVi. The downside is that costs increase as you titrate, and the program is not available in every state.
Better than MEDVi for: Lab-based monitoring, pharmacy quality control
Comparable to MEDVi for: Starting prices, enrollment experience
3. Hims/Hers: Best for Platform Experience and Reliability
If your frustration with MEDVi is operational rather than clinical, Hims may be the upgrade you are looking for. The app is polished, shipping is reliable, and the platform handles billing and subscription management smoothly. At scale, Hims has ironed out the logistics wrinkles that smaller platforms still struggle with.
The clinical model is high-volume, so you will not get deep physician engagement. But if what you need is a reliable, well-run platform that delivers medication on time and does not create billing headaches, Hims is hard to beat.
Better than MEDVi for: Platform experience, operational reliability, supply chain
Comparable to MEDVi for: Clinical depth, pricing
4. Henry Meds: Best for Simplicity and Affordability
Henry Meds strips the GLP-1 telehealth experience down to its essentials: a provider consultation, a prescription, and monthly medication delivery at $149/month. No extras, no upsells, no complexity. For patients who found MEDVi's experience basic but overpriced, Henry Meds offers an even more basic experience at a lower price.
Better than MEDVi for: Pricing, cost transparency
Not as strong as MEDVi for: Clinical depth, medication variety
5. Calibrate: Best for Comprehensive Lifestyle Integration
Calibrate takes the opposite approach from lean, medication-only programs. Their model wraps GLP-1 therapy in a comprehensive metabolic health program that includes nutrition coaching, exercise guidance, sleep optimization, and behavioral support. The price reflects that breadth, typically running $150 or more per month plus medication costs.
For patients who feel that MEDVi (or any telehealth platform) fails to address the lifestyle factors that determine long-term success, Calibrate offers a more holistic approach.
Better than MEDVi for: Lifestyle coaching, comprehensive health approach
Not as strong as MEDVi for: Affordability, simplicity
Comparison Table
| Program | Monthly Cost | Clinical Depth | Medication Options | Platform Experience | Best For |
|---|---|---|---|---|---|
| Form Blends | $199+ | High | GLP-1s + peptides | Good | Personalized physician care |
| Ro Body | $149+ | High | GLP-1s | Good | Lab-driven protocols |
| Hims/Hers | $149+ | Moderate | GLP-1s | Excellent | Reliable platform experience |
| Henry Meds | $149 | Basic | Semaglutide | Good | Lowest cost |
| Calibrate | $150+ | High | GLP-1s | Good | Lifestyle integration |
Who Should Look for a Better Option
Not every MEDVi patient needs to switch. If your protocol is producing results and your experience is positive, staying put is a perfectly valid choice. But consider making a move if:
- Your weight loss has stalled and your provider is not adapting. A plateau is normal, but how your provider responds to it matters. If the response is "keep doing what you are doing," a more engaged physician might be able to adjust your approach.
- You want peptide therapies alongside your GLP-1. MEDVi does not offer the peptide options that programs like Form Blends provide. If your treatment goals extend beyond weight loss, you need a broader formulary.
- You are paying more than you should. The GLP-1 telehealth market is competitive in 2026. If your MEDVi costs are higher than comparable programs with similar or better care, you are leaving money on the table.
- You want to feel like you have a real doctor. The difference between a provider who follows a script and a physician who knows your case and thinks critically about your protocol is significant. If you are not getting the latter, you are settling.
Frequently Asked Questions
Is MEDVi a bad program?
No. MEDVi is a legitimate telehealth GLP-1 provider that works well for many patients. "Better" does not mean MEDVi is bad. It means different programs may be stronger in areas that matter specifically to you.
What makes one GLP-1 program better than another?
The quality of physician oversight, the transparency of pricing, the breadth of medication options, and the responsiveness of customer support are the biggest differentiators. The "best" program depends on which of these factors matters most to your situation.
Will switching providers affect my results?
A smooth transition should not negatively affect your results. In fact, moving to a provider with more personalized care can sometimes restart progress that had stalled. The key is ensuring your new provider has your complete treatment history.
How do I know if my current program is good enough?
Ask yourself: Is my provider adjusting my protocol based on how I am responding? Can I reach someone when I have a question? Do I understand exactly what I am paying and why? Am I making progress toward my goals? If the answer to any of these is no, it is worth exploring alternatives.
The Bottom Line
The GLP-1 telehealth market in 2026 is mature enough that you have real choices. MEDVi is one option among many, and several alternatives offer stronger clinical care, better pricing, or broader treatment options depending on what you need. The best program is the one that matches your priorities.
Want physician-supervised GLP-1 and peptide therapy designed around your goals? Form Blends pairs you with a licensed physician who builds your protocol from scratch. No scripts, no shortcuts, no contracts.